Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation

Article de revue

Avec comité de lecture

Guillaume Manson, Pauline Brice, Charles Herbaux, Kamal Bouabdallah, Chloé Antier, Florence Poizeau, Laurent Dercle et Roch Houot

Haematologica (Roma)

13/02/2020

PMID: 32054648

Résumé

Cell Therapy and Immunotherapy

Hodgkin's Lymphoma

anti-PD1

1 Consultations de la notice

Titre: Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation
Créateurs - sans rôle: Guillaume Manson - Department of Hematology, University Hospital of Rennes, Rennes, France
Pauline Brice - Assistance Publique – Hôpitaux de Paris
Charles Herbaux - Department of Hematology, University Hospital of Lille, Lille, France
Kamal Bouabdallah - Department of Hematology, University Hospital of Bordeaux, Bordeaux, France
Chloé Antier - Department of Hematology, Nantes University Hospital, Nantes, France
Florence Poizeau - Department of Dermatology, Rennes University Hospital, Rennes, France
Laurent Dercle - Department of Radiology, Columbia University Medical Center, New York, New York, USA
Roch Houot
Détails de publication: Haematologica (Roma)
Identifiants: 99139752609311
Unité académique: Institut de Génétique Humaine - IGH
Langue: English
Type de ressource: Journal article